MYC and liver cancer: A murine animal model of primary liver cancer was established through hydrodynamic tail vein injection (HTVi) with murine transgenic constructs including pT/Caggs-NRas-V12, pT3-EF1a-C-Myc, and pCMVSB11, utilizing a prior method (15).